Related Experiment Video
Updated: Jul 4, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Impacts of depression and emotional distress on cardiac disease
1Duke University Medical Center, Durham, NC 27710, USA. Jiang001@mc.duke.edu
Insights
Depression significantly increases the risk of ischemic heart disease (IHD). Antidepressant therapy, particularly SSRIs, shows promise for improving depressive symptoms and potentially cardiac outcomes in IHD patients.
Area of Science:
- Cardiology
- Psychiatry
- Clinical Research
Background:
- Depression is a major risk factor for ischemic heart disease (IHD) and negatively impacts prognosis in patients with IHD and heart failure.
- Mental stress-induced myocardial ischemia is a key pathway linking depression to increased mortality and morbidity in IHD patients.
Purpose of the Study:
- To review the current evidence on the effects of treating depression in patients with cardiac disease.
- To evaluate the safety and efficacy of different antidepressant classes in this population.
Main Methods:
- Review of clinical trials assessing depression therapy in cardiac patients.
- Analysis of the safety profiles of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants in patients with cardiac disease.
Main Results:
- Selective serotonin reuptake inhibitors (SSRIs) are effective and relatively safe for managing depressive symptoms in cardiac patients.
- Tricyclic antidepressants present a less favorable safety profile for patients with cardiac conditions.
- Preliminary data suggest SSRI treatment may correlate with improved cardiac outcomes in depressed cardiac patients.
Conclusions:
- SSRIs are a viable treatment option for depression in patients with IHD, offering symptomatic relief and potential cardiac benefits.
- Further research is necessary to definitively establish the impact of antidepressant therapy on long-term cardiac outcomes.
Abstract:
Depression is a primary risk factor for ischemic heart disease (IHD) and a secondary risk factor for worsened prognosis in patients with IHD and heart failure. Mental stress-induced myocardial ischemia appears to be a significant mechanism by which depression increases the risk of death and morbidity in patients with IHD. A number of trials have evaluated the effect of therapy for depression in patients with cardiac disease, and more are ongoing. Selective serotonin reuptake inhibitors (SSRIs) are effective in improving depressive symptoms in cardiac patients and are relatively safe in these patients; tricyclic antidepressants are less safe in these patients. Early evidence suggests that antidepressant therapy with SSRIs may be associated with improved cardiac outcomes in depressed cardiac patients, but further study is needed.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Coronary Artery Disease I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations